Seeking Ligand Bias: Assessing GPCR Coupling to Β-Arrestins for Drug Discovery

Drug Discovery Today: Technologies - United Kingdom
doi 10.1016/j.ddtec.2010.06.005
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Lead the Way in GPCR Drug Discovery

Chemical and Engineering News
Chemical Engineering
2005English

Biased Agonism: An Emerging Paradigm in GPCR Drug Discovery

Bioorganic and Medicinal Chemistry Letters
Organic ChemistryMolecular MedicineMolecular BiologyBiochemistryClinical BiochemistryPharmaceutical ScienceDrug Discovery
2016English

Ligand Based NMR Methods for Drug Discovery

Frontiers in Bioscience - Landmark
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2009English

A New Era for GPCR Research: Structures, Biology and Drug Discovery

Acta Pharmacologica Sinica
MedicinePharmacology
2012English

Discovery of New GPCR Ligands to Illuminate New Biology

Nature Chemical Biology
Cell BiologyMolecular Biology
2017English

A SVM for GPCR Protein Prediction Using Pattern Discovery

2008English

Multifaceted Role of Β-Arrestins in Inflammation and Disease

Genes and Immunity
ImmunologyGenetics
2015English

GPCR Ligand–dendrimer (GLiDe) Conjugates: Future Smart Drugs?

Trends in Pharmacological Sciences
ToxicologyPharmacology
2010English

Β-Arrestins Regulate Stem Cell-Like Phenotype and Response to Chemotherapy in Bladder Cancer.

Molecular Cancer Therapeutics
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy